Issue of these options was dependent on the commercial project with CSIRO being deemed commercially viable after the following 2 points being met....
The last investor presentation mentioned that they were working towards making 100kg of Lidocaine Sulphate and they were engaging manufacturers to secure a commercial deal in FY20.
It looks like a license agreement may be sooner rather than later...
Ann: Appendix 3B, page-2
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.005(1.11%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 45.5¢ | 45.0¢ | $4.559K | 10.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25895 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 921 | 1 |
View Market Depth
| Last trade - 13.10pm 08/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |